Search clinical trials for: BK virus (BKV)

Total 25593 results

King Chulalongkorn Memorial Hospital

Recruiting

Prediction of BK Virus Reactivation in Kidney Transplant Recipient

BK Virus Infection | Kidney Transplant Infection | BK Virus Nephropathy

Thailand
Catherine Bollard
M.D. Anderson Cancer Center

Recruiting

Adoptive Cord Blood Immunotherapy for EBV, CMV, BKV and Adenovirus Reactivation/Infection or Prophylaxis

Viral Infection

United States
Memo Therapeutics AG

Completed

Assess Safety, Tolerability and Pharmacokinetics of AntiBKV in Healthy Adult Volunteers. (SAFE KIDNEY I)

BK Virus Nephropathy

Australia
University Hospital, Strasbourg, France

Not yet recruiting

Study of the Pathogenicity and Humoral Immune Response Induced by BK Virus in Lung Transplant Recipients (BKV-Pneumo)

Graft Rejection | Renal-urinary Impairment | Infection Episodes

France
Novartis Pharmaceuticals

Withdrawn

Determine the Safety, Tolerability, and Efficacy of MAU868 for the Prevention of BK Virus Infection in Kidney Transplant Recipients

BK Virus Nephropathy
SL VAXiGEN
SL BIGEN

Unknown

Evaluate Tolerability and Safety of BD03 for Prevention of CMV and BKV Reactivation in Kidney Transplant Recipient

BK Virus Infection | Cytomegalovirus Infections | Preventation of Cytomegalovirus Reactivation | Preventation of BK Virus Reactivation

Korea, Republic of
University of Alabama at Birmingham

Completed

BK Virus Infection (Viremia) Natural History in Renal Transplant Recipients

BK Virus (BKV) Viremia

United States
University Hospital, Strasbourg, France

Unknown

Role of Anti-BK Virus Neutralizing Antibodies (BKV) as a Prognostic Marker for the Development of Nephropathy BK

Graft Dysfunction

France
Memo Therapeutics AG

Recruiting

Safety, Tolerability and Efficacy of AntiBKV as Treatment of BKV Infection in Kidney Transplant Recipients (SAFE KIDNEY II)

BK Viremia; BKV DNAemia

United States
Nantes University Hospital

Completed

Anti-BK Virus Immune Response and Kidney Transplantation (BKv)

Kidney Transplantation

France
University Hospital, Strasbourg, France

Recruiting

Intravenous Immunoglobulins for Prevention of BKV Infection in Kidney Transplant Recipients According to BKV Genotype-specific Neutralizing Antibody Titers at the Day of Transplantation. (BKANIG)

Kidney Transplantation

France
Children's Hospital Medical Center, Cincinnati

Recruiting

Third Party Viral Specific T-cells (VSTs)

Viral Infection | Viral Reactivation | Infection in an Immunocompromised Host

United States
Children's Hospital Medical Center, Cincinnati
Hoxworth Blood Center

Recruiting

Donor-Derived Viral Specific T-cells (VSTs) (VSTs)

Allogeneic Stem Cell Transplant | Viral Infection | Viral Reactivation

United States
Lee's Pharmaceutical Limited

Not yet recruiting

An Open Study on the Preventive Effect of Early Mizoribine Conversion on BKV Nephropathy in Renal Transplant Recipients

BK Virus | Kidney Transplant Recipients

China
George Papanicolaou Hospital
University General Hospital of Patras

Recruiting

T Lymphocytes for the Treatment of AdV, CMV, EBV, BKV and Aspergillus Fumigatus Infections After Allogeneic Stem Cell Transplantation (Penta-STs-001)

Bone Marrow Transplant Infection | Opportunistic Fungal Infection | Opportunistic Viral Infection

Greece
M.D. Anderson Cancer Center

Active, not recruiting

Cidofovir Versus Best Supportive Care for Hemorrhagic Cystitis

Transplantation Infection

United States
Shenzhen Geno-Immune Medical Institute

Unknown

Antigen-specific Cytotoxic T Cells in the Treatment of Opportunistic Infections

Tuberculosis | CMV Infection | EBV Infection | Adenovirus Infection | Fungus Infection | Pathogen Infection | BKV Infection

China
University Hospital, Strasbourg, France

Recruiting

Role of Neutralizing Antibodies in the Prediction and Treatment of BK Virus Infection in Hematopoietic Stem Cell Allograft Patients at the Pediatric Oncology-hematology Department of the HUS (BKV-Allograf)

BK Virus Infection

France
Hannover Medical School
Helmholtz Centre for Infection Research; Health Insurance Audi BKK; occupational...

Recruiting

Psychosomatic, Physical Activity or Both for Post-covid19 Syndrom (TELPOCO)

Post-COVID-19 Syndrome

Germany
SymBio Pharmaceuticals

Recruiting

Study to Confirm of the Safety and Tolerability of Brincidofovir in Subjects With BK Virus Infection (Viremia) After Kidney Transplantation

BK Virus Infection | Kidney Transplantation | Nephropathy

Australia, Japan
The University of Queensland

Recruiting

A Trial to Treat Polyomavirus Infections (BKPyV) in Kidney and Simultaneous Kidney Pancreas Transplant Recipients (BEAT-BK)

Kidney Transplant Infection | Kidney Transplant Failure and Rejection | BK Viremia

Australia
University Hospital, Strasbourg, France

Not yet recruiting

New Therapeutic Approach Against BK Virus Infection Based on Monoclonal Antibodies (AcMBK)

BK Virus Infection

France
Columbia University

Recruiting

R-MVST Cells for Treatment of Viral Infections

BK Virus Infection | Epstein-Barr Virus Infections | Cytomegalovirus Infections | Adenovirus

United States
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Recruiting

Study Assessing the Feasibility, Safety and Efficacy of Genetically Engineered Glucocorticoid Receptor Knock Out Virus Specific CTL Lines for Viral Infections in Immunosuppressed Cancer Patients

Hematopoietic and Lymphoid Cell Neoplasm | Malignant Solid Neoplasm | BK Virus Infection | Symptomatic COVID-19 Infection Laboratory-Confirmed | Adenovirus Infection | Cytomegaloviral Infection | JC Virus Infection

United States
University of Wisconsin, Madison

Recruiting

BK With VST for Kidney Transplant Patients

BK Virus Infection | Kidney Transplant Infection

United States
Myanmar Liver Foundation

Recruiting

Stop Hep B @ Birth

Hepatitis B

Myanmar
ExThera Medical Europe BV
University Hospital, Essen

Not yet recruiting

Reduction of BK Viremia in Kidney Transplant Patients (CP026)

Kidney Diseases | Kidney Transplant Infection | Kidney Transplant; Complications

Germany
King Chulalongkorn Memorial Hospital

Recruiting

The Efficacy of Everolimus With Reduced-dose Tacrolimus Versus Reduced-dose Tacrolimus in Treatment of BK Virus Infection in Kidney Transplantation Recipient (ELF)

BK Virus Infection | Kidney Transplant Infection

Thailand
Centre Hospitalier Universitaire, Amiens

Recruiting

Evaluation of Renal Pretransplant Serology for BK Virus on the Risk of Post-transplant Viral Reactivation (BKSEREIN)

Kidney Transplantation | Risk Factor | BK Virus Nephropathy

France
Children's Hospital of Philadelphia

Recruiting

Treatment of BK Virus Infection With CTL Cells in Immunocompromised Transplant Patients (BK-CTLs)

BK Polyomavirus

United States
New York Medical College
Johns Hopkins University; Children's Hospital of Philadelphia; Medical College... and other collaborators

Recruiting

Treatment of Refractory BK Infections With Related Donor BK Specific Cytotoxic T-cells (CTLs)

Primary Immune Deficiency Disorder | Viral Infection

United States
Baylor College of Medicine
The Methodist Hospital Research Institute

Recruiting

TETRAVI Multivirus CTL for Treatment of EBV, CMV, Adenovirus, and BK Infections Post Allogeneic SCT. (TETRAVI)

Viral Infection

United States
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Recruiting

Cytotoxic T Lymphocytes in Treating Patients With Malignancies With BK and/or JC Virus

Acquired Immunodeficiency Syndrome | BK Virus Infection | Merkel Cell Carcinoma | Human Immunodeficiency Virus | Malignant Neoplasm | JC Virus Infection | Merkel Cell Polyomavirus Infection | Viral Encephalitis

United States
M.D. Anderson Cancer Center
National Cancer Institute (NCI)

Recruiting

Inotuzumab Ozogamicin and Combination Chemotherapy in Treating Patients With Acute Lymphoblastic Leukemia

Recurrent B Acute Lymphoblastic Leukemia | Refractory B Acute Lymphoblastic Leukemia | B Acute Lymphoblastic Leukemia, Philadelphia Chromosome Negative | B Acute Lymphoblastic Leukemia With t(9;22)(q34.1;q11.2); BCR-ABL1 | Recurrent Burkitt Lymphoma | Refractory Burkitt Lymphoma | High Grade B-Cell... and other conditions

United States
AlloVir

Terminated

Study of Posoleucel (ALVR105,Viralym-M) for Multi-Virus Prevention in Patients Post-Allogeneic Hematopoietic Cell Transplant (Prevent)

BK Virus Infection | Epstein-Barr Virus Infections | Cytomegalovirus Infections | Adenovirus Infection | JC Virus Infection | Human Herpes Virus-6 Infection

Korea, Republic of, United States, Spain, France, Turkey, Australia, United Kingdom, Italy, Canada, Belgium
AlloVir

Completed

Study of Posoleucel (Formerly Known as ALVR105; Viralym-M) in Kidney Transplant Patients With BK Viremia

BK Virus Infection | BK Virus Nephropathy

United States
AlloVir

Terminated

Study to Evaluate Viralym-M (ALVR105) for the Treatment of Virus-Associated Hemorrhagic Cystitis (HC)

BK Virus Infection | Hemorrhagic Cystitis

Korea, Republic of, United States, Italy, Sweden, United Kingdom, Spain, France
AlloVir

Completed

Posoleucel (ALVR105, Formerly Viralym-M) for Multi-Virus Prevention in Patients Post-Allogeneic Hematopoietic Cell Transplant (Prevent)

BK Virus Infection | Epstein-Barr Virus Infections | Cytomegalovirus Infections | Adenovirus Infection | JC Virus Infection | Human Herpes Virus-6 Infection

United States
Acerta Pharma BV
Merck Sharp & Dohme LLC

Active, not recruiting

ACP-196 (Acalabrutinib) in Combination With Pembrolizumab, for Treatment of Hematologic Malignancies (KEYNOTE145)

Multiple Myeloma | Hodgkin Lymphoma | Waldenström Macroglobulinemia | Burkitt Lymphoma | Small Lymphocytic Lymphoma (SLL) | Hairy Cell Leukemia | CLL | Mantle Cell Lymphoma (MCL) | Follicular Lymphoma (FL) | Richter's Syndrome | Indolent Non Hodgkin Lymphoma | Marginal Zone Lymphomas | Mediastinal Large B Cell...

United States
Children's Hospital of Philadelphia
Eunice Kennedy Shriver National Institute of Child Health and Human Development...

Active, not recruiting

VIRTUUS Children's Study (VIRTUUS)

End Stage Renal Disease | Nephropathy | Renal Transplant Rejection | Pediatric Kidney Disease | BK Virus (Nephropathy) | Antibody-mediated Rejection | Acute Cellular Graft Rejection

United States, Canada
Ottawa Hospital Research Institute
University of Manitoba; St. Joseph's Healthcare Hamilton; University Health Network... and other collaborators

Completed

Quinolone Prophylaxis for the Prevention of BK Virus Infection in Kidney Transplantation: A Pilot Study

Kidney Transplant Infection | Disease Due to BK Polyomavirus

Canada
Assistance Publique - Hôpitaux de Paris
SATT Paris Saclay

Active, not recruiting

Prediction of BKvirus Nephropathy Risk by the NEPHROVIR Method in Kidney Transplant Patients With BKvirus Viremia (BK-VIR)

BK Virus Infection | Kidney Transplantation | Nephropathy

France
Dana-Farber Cancer Institute

Active, not recruiting

Prospective Study of BK Virus Disease After Allogeneic Hematopoietic-cell Transplantation: Defining BK Disease's Natural History, Clinical Spectrum, Immunology, and Outcomes

BK Virus Infection

United States
University Hospital, Strasbourg, France

Active, not recruiting

Multicenter Randomized Two-arms Study Evaluating the BK Viral Clearance in Kidney Transplant Recipients With BK Viremia. (BK EVER)

BK Virus Nephropathy After Kidney Transplantation

France
University of North Carolina, Chapel Hill
Astellas Pharma US, Inc.

Completed

Haufen Diagnostic Biomarkers of BK Renal Disease

Polyoma Virus Nephropathy

United States
Vera Therapeutics, Inc.

Completed

A Safety, Pharmacokinetics and Efficacy Study of MAU868 for the Treatment of BK Viremia in Kidney Transplant Recipients

BK Virus Infection

United States, Canada
Centre Hospitalier Universitaire de Nice

Completed

Evaluation of a Predictive Immunovirological Test Occurrence of BK Virus Nephropathy in Renal Transplant

Renal Transplant

France
Emergex Vaccines Holding Ltd.
University of Lausanne Hospitals; Center for Primary Care and Public Health...

Completed

A Phase-I Study of a Nanoparticle-based Peptide Vaccine Against Dengue Virus

Dengue

Switzerland
Bukwang Pharmaceutical

Completed

The Proof of Concept Phase 2 Study to Evaluate the Safety and Efficacy of Clevudine in Patients With Mild and Moderate COVID-19

COVID-19

Korea, Republic of
Bukwang Pharmaceutical

Completed

The Phase 2 Study to Evaluate the Safety and Efficacy of Clevudine in Patients With Moderate COVID-19

COVID-19

Korea, Republic of

Search clinical trials for: BK virus (BKV)

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Cyprus

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations